Search results

In 2021, we estimated 4.71 million deaths were associated with bacterial AMR, including 1.14 million deaths attributable to bacterial AMR.

Effective suicide prevention strategies for autistic persons may substantially reduce the fatal burden of suicides globally and reduce the health burden experienced within this population.

Upper respiratory infections (URIs) are the leading cause of acute disease incidence worldwide and contribute to a substantial health care burden.

We estimated that in 2019, the direct health care spending attributable to ADRD across 204 countries reached $260.6 billion and the cost of informal ADRD care was $354.1 billion.

Development assistance for health provided to sub-Saharan Africa is expected to decrease in some countries, and the expected growth in government health spending might not be enough to cover this expected decline.

Liver cancer remains the leading cause of death and public health threat among the Mongolian population.

Cirrhosis mortality increased nationally and in many counties from 2000 to 2019.

We present the most up-to-date global, regional, and national estimates for prevalence and years lived with disability (YLDs) due to gout by sex, age, and location from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, as well as forecasted prevalence to 2050.

In this geospatial modelling analysis, we developed an integrated database containing information on the distribution of Nipah virus infections in humans and animals from 1998 to 2021.

The economic crisis that began in 2008 has severely affected Southern (Greece, Italy, Portugal, Spain) Western European (SWE) countries of Western Europe (WE) and may have affected ongoing efforts to eliminate viral hepatitis.

The State of Global Air report and website bring into one place a comprehensive analysis of the levels and trends in air quality and health for every country in the world.

We used the metric of incremental cost-effectiveness ratio (ICER) to determine which interventions are most cost-effective among 14 recommended interventions for Global Fund-eligible countries.